Bone Mineral Density Changes in People with HIV Who had Immediate Switch Versus Deferred Switch from Tenofovir Disoproxil Fumarate-Based Regimens to Bictegravir/Emtricitabine/Tenofovir Alafenamide: A Multicenter, Open-Label, Randomized Clinical Trial.

Saved in:
Bibliographic Details
Title: Bone Mineral Density Changes in People with HIV Who had Immediate Switch Versus Deferred Switch from Tenofovir Disoproxil Fumarate-Based Regimens to Bictegravir/Emtricitabine/Tenofovir Alafenamide: A Multicenter, Open-Label, Randomized Clinical Trial.
Authors: Shao, Yueming1 (AUTHOR), Yang, Xinping2 (AUTHOR), Yu, Jianhua3 (AUTHOR), Wang, Xicheng2 (AUTHOR), Wang, Jiangrong1 (AUTHOR), Liu, Mei2 (AUTHOR), Yang, Zongxing3 (AUTHOR), Han, Jie3 (AUTHOR), Zhang, Renfang1 (AUTHOR), Liu, Li1 (AUTHOR), Shen, Yinzhong1 (AUTHOR), Sun, Meiyan1 (AUTHOR), Wu, Luling4 (AUTHOR), Zheng, Zhihang5 (AUTHOR), Tang, Yang1 (AUTHOR), Yang, Junyang1 (AUTHOR), Wang, Zhenyan1 (AUTHOR), Qi, Tangkai1 (AUTHOR), Xu, Shuibao1 (AUTHOR), Xun, Jingna1 (AUTHOR)
Source: Infectious Diseases & Therapy. Jan2026, Vol. 15 Issue 1, p165-181. 17p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:21938229
DOI:10.1007/s40121-025-01262-8